Reduction of LV dP/dtmax by Intravenous Cibenzoline Predicts the Efficacy of Its Oral Administration in Patients with Hypertrophic Obstructive Cardiomyopathy.
Reduction of LV dP/dtmax by Intravenous Cibenzoline Predicts the Efficacy of Its Oral Administration in Patients with Hypertrophic Obstructive Cardiomyopathy.
复制标题
静脉注射西苯唑啉降低 LV dP/dtmax 可以预测其口服给药对肥厚性梗阻性心肌病患者的疗效。
DOI：
--
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
and Tohru Minamino
中科院分区：
文献类型：
--
作者：
Tohru Watanabe;Takeshi Kashimura;Hiromi Kayamori;Hiroaki Obata;Haruo Hanawa;and Tohru Minamino
